|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019004,
umls-concept:C0019046,
umls-concept:C0030705,
umls-concept:C0035286,
umls-concept:C0206161,
umls-concept:C0302583,
umls-concept:C0348016,
umls-concept:C0456205,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1515075,
umls-concept:C1524112,
umls-concept:C1550605,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-1-24
|
|
pubmed:abstractText |
Optimal response to recombinant human erythropoietin (rHuEpo) in haemodialysis (HD) patients requires provision of sufficient available iron. However, a balance between iron requirements and supplements remains a challenge in clinical practice. Reticulocyte parameters, i.e. reticulocyte haemoglobin content (CHr) and reticulocytes in a high-fluorescence intensity region (HFR), have been shown to be accurate predictors of iron-deficient erythropoiesis as compared with traditional markers. Therefore, the aim of this study was to appraise the diagnostic power of these two parameters in the early prediction of response to intravenous iron (IVFE) medications in HD patients receiving rHuEpo.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
370-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12543894-Anemia, Iron-Deficiency,
pubmed-meshheading:12543894-Erythropoiesis,
pubmed-meshheading:12543894-Erythropoietin,
pubmed-meshheading:12543894-Female,
pubmed-meshheading:12543894-Ferric Compounds,
pubmed-meshheading:12543894-Fluorescence,
pubmed-meshheading:12543894-Hemoglobins,
pubmed-meshheading:12543894-Humans,
pubmed-meshheading:12543894-Injections, Intravenous,
pubmed-meshheading:12543894-Male,
pubmed-meshheading:12543894-Middle Aged,
pubmed-meshheading:12543894-Predictive Value of Tests,
pubmed-meshheading:12543894-Prognosis,
pubmed-meshheading:12543894-Prospective Studies,
pubmed-meshheading:12543894-Recombinant Proteins,
pubmed-meshheading:12543894-Renal Dialysis,
pubmed-meshheading:12543894-Reticulocyte Count,
pubmed-meshheading:12543894-Reticulocytes
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
|
|
pubmed:affiliation |
Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
